Egypt’s Rameda reports EGP 245mln net profit growth in 2022

Egypt’s Rameda Pharmaceutical’s net profit increased to reach 245.676 million Egyptian pounds in 2022, up from 181.088 million pounds in 2021, according to its consolidated financial statement filed to EGX on Tuesday.

The statement showed that Rameda has generated consolidated revenue of 1.483 billion pounds in the full-year ended December 31st 2022, jumping from 1.246 billion pounds in 2021, and recording 19 percent growth.

Meanwhile, Rameda’s standalone net profit after tax rose to 234.644 million pounds last year, compared to 182.205 million pounds in 2021, the financial statement added.